Jazz Pharmaceuticals, Inc. (Jobs) Files for $172.5 Million IPO

WASHINGTON, March 9 (Reuters) - Jazz Pharmaceuticals, which focuses on developing products for neurology and psychiatry medical needs, filed with regulators on Friday to raise up to $172.5 million in an initial public offering of stock.

>>> Discuss This Story